Clinica Baviera SA
XBER:D9Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Clinica Baviera SA
XBER:D9Z
|
ES |
|
A
|
Alliance Resources Ltd
F:A5P
|
AU |
|
E
|
Elkem ASA
F:1DP
|
NO |
|
Interworks Inc
TSE:6032
|
JP |
|
Faron Pharmaceuticals Oy
F:4FR
|
FI |
|
Boss Holdings Inc
OTC:BSHI
|
US |
|
L
|
Lucy Scientific Discovery Inc
OTC:DOSEF
|
CA |
|
C
|
Cantex Mine Development Corp
OTC:CTXDF
|
CA |
|
D
|
Desert Gold Ventures Inc
F:QXR2
|
CA |
|
FLEX LNG Ltd
LSE:0RQ8
|
BM |
|
K
|
Kyowa Kirin Co Ltd
F:KY4
|
JP |
|
S
|
Square Enix Holdings Co Ltd
XBER:EI4
|
JP |
|
T
|
Tokyo Kikai Seisakusho Ltd
TSE:6335
|
JP |
Dividends
Dividend Yield
Clinica Baviera SA
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Clinica Baviera SA
D9Z have decreased by 0%.
Payout Ratio
Clinica Baviera SA
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for D9Z is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
D9Z Price
Clinica Baviera SA
| Average Annual Return | 10.1% |
| Standard Deviation of Annual Returns | 25.75% |
| Max Drawdown | -35% |
| Market Capitalization | 955.6m EUR |
| Shares Outstanding | 10 519 026 |
| Percentage of Shares Shorted |
N/A
|
